naltrexone protective_against alcohol dependence

Subject: naltrexone
Relation: protective_against
Object: alcohol dependence
p-value: —

Evidence from: primary | all sources

Evidence (5 sources)

Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018) PMID:30167705 cited

FDA’s approval of that dosage for treating alcohol dependence

confidence: 0.90

Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012) PMID:22954510 cited

effects of naltrexone on alcohol-related phenotypes

confidence: 0.90

Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012) PMID:22954510 cited

treatment efficacy of naltrexone for alcohol dependence

confidence: 0.85

Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012) PMID:22954510 cited

naltrexone was an effective treatment for alcohol dependence when delivered in combination with a medically-oriented behavioral intervention

confidence: 0.94

Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012) PMID:22954510 cited

moderate efficacy of naltrexone for alcohol dependence

confidence: 0.85